PE20010701A1 - ONCOLITIC COMBINATIONS FOR THE TREATMENT OF CANCER - Google Patents
ONCOLITIC COMBINATIONS FOR THE TREATMENT OF CANCERInfo
- Publication number
- PE20010701A1 PE20010701A1 PE2000001206A PE0012062000A PE20010701A1 PE 20010701 A1 PE20010701 A1 PE 20010701A1 PE 2000001206 A PE2000001206 A PE 2000001206A PE 0012062000 A PE0012062000 A PE 0012062000A PE 20010701 A1 PE20010701 A1 PE 20010701A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- cycloalkyl
- cancer
- carcinoma
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE a)UN ANTAGONISTA DE LEUCOTRIENO (LTB4) DE FORMULA I, X ES UN HETEROCICLO DE 5 MIEMBROS CON 1-4 HETEROATOMOS, BICICLO; Y ES UN ENLACE O UN GRUPO DIVALENTE CON 1-9 ATOMOS; Y2, Y3 SON CH2, O, S,; Z ES UN GRUPO ACIDICO; R1 ES ALQUILO C1-C6, ARILO, CICLOALQUILO C2-C10, ENTRE OTROS; R2 ES H, HALOGENO, HALOALQUILO C1-C10, ALCOXI C1-C10, ENTRE OTROS; R3 ES H, HALOGENO, ALQUILO C1-C10, ARILO, ENTRE OTROS; R4 ES ALQUILO C1-C4, CICLOALQUILO C3-C4, CH2(1-7)(CICLOALQUILO C3-C4), ENTRE OTROS; M ES 0-6; UN COMPUESTO PREFERIDO ES 2-[2-PROPIL-3-[3-[2-ETIL-5-HIDROXI-4-(4-FLUOROFENIL)FENOXI]PROPOXI]FENOXI ACIDO BENZOICO Y b)UN AGENTE ANTICANCEROSO 2`,2'-DIFLUORONUCLEOSIDO DE FORMULA II, DONDE R1 ES H, -COR5; R2 ES UN GRUPO a, b; X ES N, CR4; R3 ES H, ALQUILO C1-C4, COR5; R4 ES H, ALQUILO C1-C4, AMINO, Br, ENTRE OTROS; R5 ES H, ALQUILO C1-C4; UN COMPUESTO PREFERIDO ES GEMCITABINA HCl, 2'-DEOXI-2',2'-DIFLUOROCITIDINA MONOCLORHIDRATO (ß-ISOMERO). LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DEL CANCER, CARCINOMA DE MAMA, CARCINOMA DE VEJIGA, CARCINOMA COLORECTAL, CARCINOMA ESOFAGICOREFERS TO A COMPOSITION INCLUDING a) A LEUCOTRIENE ANTAGONIST (LTB4) OF FORMULA I, X IS A 5-MEMBER HETEROCYCLE WITH 1-4 HETEROATOMS, BICYCLE; AND IT IS A LINK OR A DIVALENT GROUP WITH 1-9 ATOMS; Y2, Y3 ARE CH2, O, S ,; Z IS AN ACIDIC GROUP; R1 IS C1-C6 ALKYL, ARYL, C2-C10 CYCLOALKYL, AMONG OTHERS; R2 IS H, HALOGEN, C1-C10 HALOALKYL, C1-C10 ALCOXY, AMONG OTHERS; R3 IS H, HALOGEN, C1-C10 ALKYL, ARYL, AMONG OTHERS; R4 IS C1-C4 ALKYL, C3-C4 CYCLOALKYL, CH2 (1-7) (C3-C4 CYCLOALKYL), AMONG OTHERS; M IS 0-6; A PREFERRED COMPOUND IS 2- [2-PROPYL-3- [3- [2-ETHYL-5-HYDROXY-4- (4-FLUOROPHENYL) PHENOXY] PROPOXY] PHENOXY BENZOIC ACID AND b) AN ANTI-CANCER AGENT 2`, 2 ' -DIFLUORONUCLEOSIDE OF FORMULA II, WHERE R1 IS H, -COR5; R2 IS A GROUP a, b; X IS N, CR4; R3 IS H, C1-C4 ALKYL, COR5; R4 IS H, C1-C4 ALKYL, AMINO, Br, AMONG OTHERS; R5 IS H, C1-C4 ALKYL; A PREFERRED COMPOUND IS GEMCITABIN HCl, 2'-DEOXI-2 ', 2'-DIFLUOROCYTIDINE MONOCLORHYDRATE (ß-ISOMER). THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF CANCER, BREAST CARCINOMA, BLADDER CARCINOMA, COLORECTAL CARCINOMA, ESOPHAGEAL CARCINOMA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16478699P | 1999-11-11 | 1999-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010701A1 true PE20010701A1 (en) | 2001-07-07 |
Family
ID=22596085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001206A PE20010701A1 (en) | 1999-11-11 | 2000-11-10 | ONCOLITIC COMBINATIONS FOR THE TREATMENT OF CANCER |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1231938A2 (en) |
| JP (1) | JP2003513916A (en) |
| KR (1) | KR20020069512A (en) |
| CN (1) | CN1390139A (en) |
| AR (1) | AR032432A1 (en) |
| AU (1) | AU778829B2 (en) |
| BR (1) | BR0015490A (en) |
| CA (1) | CA2391416A1 (en) |
| CZ (1) | CZ20021551A3 (en) |
| EA (1) | EA200200545A1 (en) |
| HK (1) | HK1050132A1 (en) |
| HU (1) | HUP0204449A3 (en) |
| IL (1) | IL148579A0 (en) |
| MX (1) | MXPA02004733A (en) |
| NO (1) | NO20022245L (en) |
| NZ (1) | NZ517667A (en) |
| PE (1) | PE20010701A1 (en) |
| PL (1) | PL355172A1 (en) |
| SK (1) | SK6492002A3 (en) |
| TR (1) | TR200201245T2 (en) |
| WO (1) | WO2001034137A2 (en) |
| ZA (1) | ZA200202822B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6797723B1 (en) | 1999-11-11 | 2004-09-28 | Eli Lilly And Company | Heterocycle substituted diphenyl leukotriene antagonists |
| WO2001034198A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU1916501A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| JP2001247459A (en) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | Combination therapy for cancer |
| EP1326605A4 (en) * | 2000-05-09 | 2004-03-17 | Univ Creighton | Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| AU2001282717A1 (en) | 2000-07-28 | 2002-02-13 | Cancer Research Technology Limited | Cancer treatment by combination therapy |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
| US7968723B2 (en) | 2004-05-05 | 2011-06-28 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
| US8053598B2 (en) | 2004-05-05 | 2011-11-08 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
| CN1302782C (en) * | 2005-01-17 | 2007-03-07 | 北京京卫燕康药物研究所有限公司 | Jixitabing hydrochloride solution type injection agent |
| EP2298742B1 (en) | 2005-06-30 | 2014-01-08 | High Point Pharmaceuticals, LLC | phenoxy acetic acids as PPAR delta activators |
| BRPI0620468A2 (en) | 2005-12-22 | 2011-11-08 | Transtech Pharma Inc | acetic phenoxy acids as activators of delta ppar |
| CA2645719A1 (en) | 2006-03-09 | 2007-09-13 | High Point Pharmaceuticals, Llc | Compounds that modulate ppar activity, their preparation and use |
| AU2007307597A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivatives |
| US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
| WO2014060381A1 (en) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclic compounds as pesticides |
| BR112015009751A2 (en) | 2012-10-31 | 2017-07-11 | Bayer Cropscience Ag | new heterocyclic compounds as pesticides |
| CN103319466B (en) * | 2013-07-04 | 2016-03-16 | 郑州大学 | Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
-
2000
- 2000-11-09 MX MXPA02004733A patent/MXPA02004733A/en not_active Application Discontinuation
- 2000-11-09 AU AU15990/01A patent/AU778829B2/en not_active Ceased
- 2000-11-09 HU HU0204449A patent/HUP0204449A3/en unknown
- 2000-11-09 JP JP2001536137A patent/JP2003513916A/en not_active Withdrawn
- 2000-11-09 CZ CZ20021551A patent/CZ20021551A3/en unknown
- 2000-11-09 KR KR1020027006027A patent/KR20020069512A/en not_active Application Discontinuation
- 2000-11-09 PL PL00355172A patent/PL355172A1/en not_active Application Discontinuation
- 2000-11-09 WO PCT/US2000/031039 patent/WO2001034137A2/en active IP Right Grant
- 2000-11-09 NZ NZ517667A patent/NZ517667A/en unknown
- 2000-11-09 CA CA002391416A patent/CA2391416A1/en not_active Abandoned
- 2000-11-09 CN CN00815579A patent/CN1390139A/en active Pending
- 2000-11-09 SK SK649-2002A patent/SK6492002A3/en unknown
- 2000-11-09 IL IL14857900A patent/IL148579A0/en unknown
- 2000-11-09 TR TR2002/01245T patent/TR200201245T2/en unknown
- 2000-11-09 EA EA200200545A patent/EA200200545A1/en unknown
- 2000-11-09 BR BR0015490-3A patent/BR0015490A/en not_active IP Right Cessation
- 2000-11-09 EP EP00978535A patent/EP1231938A2/en not_active Withdrawn
- 2000-11-10 PE PE2000001206A patent/PE20010701A1/en not_active Application Discontinuation
- 2000-11-10 AR ARP000105955A patent/AR032432A1/en unknown
-
2002
- 2002-04-10 ZA ZA200202822A patent/ZA200202822B/en unknown
- 2002-05-10 NO NO20022245A patent/NO20022245L/en not_active Application Discontinuation
-
2003
- 2003-01-29 HK HK03100750.7A patent/HK1050132A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0015490A (en) | 2002-07-09 |
| SK6492002A3 (en) | 2003-09-11 |
| EA200200545A1 (en) | 2002-12-26 |
| PL355172A1 (en) | 2004-04-05 |
| IL148579A0 (en) | 2002-09-12 |
| AU1599001A (en) | 2001-06-06 |
| JP2003513916A (en) | 2003-04-15 |
| TR200201245T2 (en) | 2004-08-23 |
| AU778829B2 (en) | 2004-12-23 |
| NO20022245L (en) | 2002-07-09 |
| HUP0204449A2 (en) | 2003-04-28 |
| EP1231938A2 (en) | 2002-08-21 |
| CA2391416A1 (en) | 2001-05-17 |
| MXPA02004733A (en) | 2002-08-30 |
| NO20022245D0 (en) | 2002-05-10 |
| AR032432A1 (en) | 2003-11-12 |
| ZA200202822B (en) | 2003-09-23 |
| CZ20021551A3 (en) | 2003-02-12 |
| CN1390139A (en) | 2003-01-08 |
| WO2001034137A2 (en) | 2001-05-17 |
| NZ517667A (en) | 2004-05-28 |
| HUP0204449A3 (en) | 2006-02-28 |
| HK1050132A1 (en) | 2003-06-13 |
| KR20020069512A (en) | 2002-09-04 |
| WO2001034137A3 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010701A1 (en) | ONCOLITIC COMBINATIONS FOR THE TREATMENT OF CANCER | |
| TR200103474T2 (en) | New uses of the compositions as an antibacterial agent | |
| PE20060427A1 (en) | PIRAZOLE DERIVATIVES AS GLUCAGON BINDING INHIBITORS AND COMPOSITIONS | |
| PE20001483A1 (en) | OXAMIC ACIDS AND DERIVATIVES AS LIGANDS OF THYROID RECEPTORS | |
| SE9704404D0 (en) | New compounds | |
| TR200000837A2 (en) | Process and intermediates to prepare anti-cancer compositions. | |
| PE20081448A1 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| PT1041072E (en) | DIOXOCYCLOPENTIL HYDROXYM ACIDS | |
| PE20080706A1 (en) | ARYLMIDAZOLONES AND ARYLTHRIAZOLONES SUBSTITUTED AS VASOPPRESSIN RECEPTOR INHIBITORS | |
| PE20061303A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING OXAPROZIN | |
| PE20091527A1 (en) | PYRIDAZINONE DERIVATIVES | |
| ATE369845T1 (en) | TREATING THE SIDE EFFECTS OF STATINS | |
| CY1105160T1 (en) | OXAZOLE DERIVATIVES WITH CARBOXYLIC ACID SUBSTITUENTS FOR USE AS PPAR-α AND -γ ACTIVATORS FOR THE TREATMENT OF DIABETES | |
| MA28747B1 (en) | Pyridine Derivatives | |
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| CY1108367T1 (en) | PAINYL-CARBOXAMID COMPOUNDS USEFUL FOR PANTS | |
| TR200003383T2 (en) | Compositions for the treatment of HIV and other virus infections. | |
| SE9700661D0 (en) | New compounds | |
| MY129310A (en) | C-4 carbonate taxanes | |
| SE9602286D0 (en) | New compounds | |
| BR0206552A (en) | Use of at least one quinoline, quinoline, and pharmaceutical composition | |
| PE20001083A1 (en) | MONONITRATE DERIVATIVES OF ISOSORBIDE | |
| PL344056A1 (en) | Piperididinyl and n-amidinopiperidinyl derivatives | |
| ATE340572T1 (en) | BENZAZOLE DERIVATIVES FOR THE TREATMENT OF SCLERODERMA | |
| ATE408610T1 (en) | ALKYL AND PIPERIDINE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |